The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 655.00
Bid: 658.00
Ask: 659.00
Change: -0.50 (-0.08%)
Spread: 1.00 (0.152%)
Open: 643.00
High: 664.00
Low: 643.00
Prev. Close: 655.50
TATE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

23 Jul 2020 07:00

RNS Number : 8095T
Tate & Lyle PLC
23 July 2020
 

23 July 2020 - Tate & Lyle PLC

 

 

TRADING STATEMENT

 

Tate & Lyle issues the following trading statement for the three months to 30 June 2020.

 

As anticipated in our trading update on 4 May 2020 and in our full-year results statement on 21 May 2020, the Group's performance in the first quarter reflected the impact of lockdowns on out-of-home consumption in North America and Europe, partially offset by resilience from in-home consumption. Having seen fluctuating demand patterns in April and May, demand improved in both divisions in June as lockdowns started to ease. The full extent of the pandemic's impact still remains unclear.

 

Our response to Covid-19 has successfully focused on ensuring we look after the health, safety and wellbeing of our colleagues, their families and the local communities in which we operate; and to work closely with our customers to play our part in supporting the food supply chain with all our manufacturing facilities remaining fully operational in the quarter.

 

Three months ended 30 June 2020

Volume change

Revenue growth*

 

Food & Beverage Solutions

 

(2%)

 

+1% 

Sucralose

(2%)

(1%)

Primary Products

(12%)

(9%)

 

 

 

Group

 

(5%)

 

* Growth in constant currency

 

Food & Beverage Solutions

Revenue was £232 million, 1% higher benefiting from good price and mix management and 9% growth in New Products[1] revenue. Volume was 2% lower as reduced demand for ingredients used in food and drink consumed out-of-home (representing 15% to 25% of revenue) outweighed stronger demand for packaged and shelf-stable foods for consumption in-home.

 

In North America, revenue for the quarter was 2% lower due to reduced demand for out-of-home consumption particularly in the food service sector. North America returned to revenue growth in June as lockdown restrictions eased. In Europe, Middle East and Africa revenue was in line with the comparative period reflecting solid demand for in-home consumption. In Asia Pacific and Latin America revenue was 8% higher reflecting good revenue growth in Asia Pacific as China emerged from lockdown, while in Latin America revenue grew modestly, slowing as the quarter progressed and the region went into lockdown.

 

Sucralose

Revenue was £39 million, 1% lower reflecting softer demand for products consumed out-of-home, particularly beverages.

 

Primary Products

Revenue was £420 million, 9% lower. North American bulk sweetener volume was 12% lower reflecting reduced out-of-home consumption (representing around 30% of sweetener consumption) with demand recovering sequentially during the quarter as some US states began to ease lockdown restrictions. Industrial starch volume was 16% lower as the paper industry took actions to reduce capacity temporarily with many schools and offices still closed.

 

Reducing costs and preserving cash

The financial impact of lower demand was partially mitigated by actions taken to reduce costs including freezing salary increases and recruitment and significantly reducing discretionary costs. Procedures were also put in place to preserve cash through re-prioritising capital commitments and a rigorous approach to managing working capital. No employees have been furloughed and no government aid has been sought.

 

Strong balance sheet

Our balance sheet is strong with net debt at 30 June 2020 of £384 million, £67 million lower than at 31 March 2020 reflecting seasonal improvement and good cash management.

 

Nick Hampton, Chief Executive said:

"As expected, the first quarter presented many challenges and I am very proud of the way we are navigating the impact of Covid-19. We are encouraged by the improvement in demand we saw in June and the continued strategic progress we are making, with new product revenue growing 9% in the quarter. Our new business pipeline is healthy, we continue to find creative ways to use technology to support and connect with our customers, and all our manufacturing facilities remain fully operational.

 

The fundamentals of our business are sound. Demand for ingredients and solutions which enable consumers to enjoy healthier and tastier food and drink is strong, and we have the portfolio of products and technical expertise to help our customers deliver on these trends.

 

Looking ahead, our priorities are clear - to look after our people and communities, strengthen our relationships with customers, continue to progress our strategy and maintain our financial strength. I am confident that our future prospects remain strong."

 

 

 

For more information contact Tate & Lyle PLC:

Christopher Marsh, VP, Investor Relations

Tel: Mobile: +44 (0) 7796 192 688

 

Nick Hasell, FTI Consulting (Media)

Tel: Mobile: +44 (0) 7825 523 383

 

 

About Tate & Lyle:

Tate & Lyle is a global provider of solutions and ingredients for food, beverage and industrial markets.

Tate & Lyle operates through two global divisions, Food & Beverage Solutions and Primary Products, supported by the Innovation and Commercial Development and Global Operations teams. Food & Beverage Solutions is focused on growth by building leading positions globally in the categories of beverages, dairy, and soups, sauces and dressings. Primary Products is focused on delivering steady earnings and generating cash.

Food & Beverage Solutions consists of: Texturants, including speciality starches; Sweeteners, including low- and no-calorie sweeteners; and a Health and Wellness portfolio comprising mainly speciality fibres; and Stabilisers and Functional Systems, which are bespoke ingredient blends that ensure foods retain their structure.

Primary Products consists of high-volume sweeteners, industrial starches and fermentation products (primarily acidulants). It also sells co-products from the corn milling process as animal nutrition.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2020, Tate & Lyle revenue totalled £2.9 billion. For more information, please visit http://www.tateandlyle.com or follow Tate & Lyle on Twitter or LinkedIn.

 

 

 

[1] New Products are products launched in the last seven years

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKBBKABKDFOB
Date   Source Headline
8th Dec 20172:39 pmBUSDirector Declaration
4th Dec 20171:40 pmBUSDirector/PDMR Shareholding
24th Nov 201712:54 pmBUSDirector/PDMR Shareholding
20th Nov 20173:21 pmBUSHolding(s) in Company
16th Nov 20171:17 pmBUSHolding(s) in Company
13th Nov 20171:08 pmBUSHolding(s) in Company
2nd Nov 20177:00 amBUSHalf-year Report
1st Nov 20175:00 pmBUSHolding(s) in Company
19th Sep 20174:16 pmBUSHolding(s) in Company
13th Sep 201710:00 amBUSDirector/PDMR Shareholding
1st Sep 201710:00 amBUSTotal Voting Rights
17th Aug 201711:38 amBUSDirector/PDMR Shareholding
9th Aug 20174:00 pmBUSDirectorate change
3rd Aug 201711:00 amBUSResult of the External Audit Tender
27th Jul 20172:37 pmBUSResult of AGM
27th Jul 20177:00 amBUSTrading Statement
3rd Jul 201712:35 pmBUSTotal Voting Rights
3rd Jul 201712:34 pmBUSBlock listing Interim Review
30th Jun 20173:36 pmBUSDirector/PDMR Shareholding
29th Jun 20173:37 pmBUSDirector/PDMR Shareholding
26th Jun 20173:40 pmBUSDirector/PDMR Shareholding
19th Jun 20174:21 pmBUSAnnual Financial Report
16th Jun 20174:20 pmBUSDirector/PDMR Shareholding
14th Jun 20174:31 pmBUSHolding(s) in Company
1st Jun 20173:40 pmBUSTotal Voting Rights
31st May 20173:11 pmBUSHolding(s) in Company
26th May 201711:40 amBUSHolding(s) in Company
25th May 20177:00 amBUSFinal Results
18th May 20172:40 pmBUSHolding(s) in Company
2nd May 201711:55 amBUSTotal Voting Rights
26th Apr 201710:52 amBUSHolding(s) in Company
11th Apr 20175:05 pmBUSDirector/PDMR Shareholding
4th Apr 20173:09 pmBUSDirector/PDMR Shareholding
4th Apr 201710:53 amBUSTotal Voting Rights
1st Mar 20179:58 amBUSTotal Voting Rights
16th Feb 20176:21 pmBUSTransaction in Own Shares
15th Feb 20176:18 pmBUSTransaction in Own Shares
14th Feb 20175:54 pmBUSTransaction in Own Shares
13th Feb 20176:26 pmBUSTransaction in Own Shares
13th Feb 201710:09 amBUSDirector/PDMR Shareholding
9th Feb 20177:00 amBUSTrading Statement
1st Feb 201712:18 pmBUSCompany Secretary Change
1st Feb 201710:00 amBUSTotal Voting Rights
20th Jan 20175:42 pmBUSTransaction in Own Shares
19th Jan 20175:51 pmBUSTransaction in Own Shares
18th Jan 20175:52 pmBUSTransaction in Own Shares
17th Jan 20175:39 pmBUSTransaction in Own Shares
16th Jan 20176:07 pmBUSTransaction in Own Shares
13th Jan 20176:13 pmBUSTransaction in Own Shares
13th Jan 20179:43 amBUSCommencement of Share Purchase Programme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.